PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honours Mibelle Biochemistry for its Discovery of Snow Algae Powder, an Active Ingredient for Anti-Ageing Skin Care Products - Mibelle Biochemistry has perfectly combined natural resources and biotechnology to produce the peerless Snow Algae Powder - MibelleBiochemistry.com / Frost.com
Frost & Sullivan Honours Mibelle Biochemistry for its Discovery of Snow Algae Powder, an Active Ingredient for Anti-Ageing Skin Care Products

 

NewswireToday - /newswire/ - London, United Kingdom, 2014/11/05 - Mibelle Biochemistry has perfectly combined natural resources and biotechnology to produce the peerless Snow Algae Powder - MibelleBiochemistry.com / Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the anti-ageing skin care market, Frost & Sullivan recognizes Mibelle Biochemistry with the 2014 European Award for New Product Innovation Leadership.

Mibelle Biochemistry has been highly successful in leveraging its technological expertise to produce Snow Algae Powder, an active ingredient for anti-aging skincare products. By combining sustainable technology with effective production methods, Mibelle Biochemistry has designed the most productive active agent for the cosmetic industry.

The production process of the active ingredient involves initial isolation of the algae, followed by enhanced cultivation in bio-reactors. Optimal cultivation of the snow algae powder in the bio-reactor enhances the production of stress response molecules, eg. carotenoids which are very valuable for the skin. Further, the snow algae are harvested for purification, the cell walls of the algae are disrupted and the cell fragments are encapsulated into liposomes. Finally, the algae are spray-dried on a maltodextrin-based powder.

Mibelle Biochemistry's advanced encapsulation technology enables optimum bioavailability of the extract. Its best practices also guarantee that the ingredient is uncontaminated by pollutants or pesticides.

The Snow Algae Powder stimulates Klothogene, a highly efficient anti-aging stimulant, by as much as 47 percent. The resulting boost in the activated protein kinase α (AMPK) creates a protective cover against excess calories and prevents the reduction of AMPK over age.

"Snow algae are the only algae that increase the amount of Klothogene in the skin. It helps in DNA repair and detoxification of skin cells, and stimulates calorie restriction mimetics," said Frost & Sullivan Vice President Shomik Majumdar. "Furthermore, with this ingredient, Mibelle Biochemistry pioneered the improvement of the papillary structure at the dermal-epidermal junction for skin rejuvenation."

Additionally, Snow Algae Powder can neutralize collagen degradation by stimulating its production and forming a barrier against the enzymes that destroy collagen. It also reduces water loss of the skin through the epidermis, thereby reducing dryness and skin ageing.

Mibelle Biochemistry has not only focused on producing superior products but has also educated its customers and end users on the benefits of snow algae and their cultivation. It allows its customers to use the logo of Snow Algae Powder, free of cost, on the label of the final product.

Mibelle Biochemistry has patented use of snow algae extract in cosmetics, giving it a first-mover advantage. Frost & Sullivan expects its unique strategy in marketing the product as a whole package to drive its rapid adoption.

"Mibelle Biochemistry uses zero preservatives and consistent concentration of metabolites," noted Industry Analyst Nandhini Rajagopal. "This strict procedure and its customized bioreactors ensure that the Snow Algae Powder offers superior quality and unmatched value to customers."

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leverage leading-edge technologies. The award recognizes the value added features/benefits of the product and the increased ROI it offers customers, which in turn increases customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Mibelle Biochemistry
Inspired by nature Realized by science

Mibelle Biochemistry (mibellebiochemistry.com), a Swiss company, is specialized in the research and development of innovative, high-quality actives for the cosmetic industry. Inspired by nature Mibelle Biochemistry transforms naturally derived compounds into truly functional cosmetic ingredients. Furthermore Mibelle Biochemistry possesses powerful encapsulation technologies that guarantee optimum bioavailability. All products are accompanied by comprehensive technical support and marketing-oriented documentation.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation

Contact: Beata Hurst - Head of Marketing
Mibelle Biochemistry
E: beata.hurst[.]mibellegroup.com - P: +41 62 836 17 46

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honours Mibelle Biochemistry for its Discovery of Snow Algae Powder, an Active Ingredient for Anti-Ageing Skin Care Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | Mibelle Biochemistry
Publisher Contact: Kristina Menzefricke - Frost.com 
+44(0)20 7915 7869 kristina.menzefricke[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)